Xvivo System® model X2
— Cytocentric® by Design
The 21st Century GMP Quality Platform for processing and producing clinical grade cells.
Alfred State Students visit BioSpherix
Modernizing Therapeutic Cell Production
Testing Facility Called “Game Changer” in Regenerative Medicine
World’s First Cytocentric® Testing Facility
With the installation of one machine, Adelaide becomes a leading center of excellence in the treatment of pancreatitis
BioSpherix Collaborates with Industry Leaders at the New RegeneratOR Test Bed to Advance Regenerative Medicine
BioSpherix partners with Sexton Biotechnologies on modular fill-finish for cell and gene therapies
Next Generation Isolators at Canadian Hospitals to begin COVID-19 clinical trials
BioSpherix ramps up production again after COVID pause!
Selecting The Right Isolator For Cell Therapy Manufacturing: Considerations & Challenges
More Cell and Gene Therapy Facilities in the Hundreds are Needed
Point-of-Use Inoculum Prep
ISPE 2019: Closing Down the Process – The Future of Cell and Gene Therapy Manufacturing
Cleanrooms West and BioSpherix Medical Collaboration
Hodess Cleanrooms Installs GMP Isolator Into Wall
Testimonial: Bristol-Myers Squibb
BioSpherix Announces Facility and Capacity Expansion
BioSpherix seen on National Geographic: Miracle Hospital
Could reducing cell manufacturing fluctuations help customers like Novartis improve their cell variability issues for Kymriah?
Institute for Vision Research Announces a Culture System for Human Donor Retina
BioSpherix Sponsors the 2018 ISSCR Meeting in Melbourne!
BioSpherix Medical at ASGCT
BioSpherix Medical at ISCT in Montreal
BioSpherix Medical Announces Successful Completion of F.A.T. Test
BioSpherix Medical will be attending Interphex in NYC